Search - tctmd.com

Displaying 981 - 1000 of 1352

Sort: Relevancy | Date

Presentation

Antisense Inhibition of Apolipoprotein C-III in Patients With Hypertriglyceridemia

Presenter: D. Gaudet

August 12, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

Yael L. Maxwell

August 12, 2015

News Daily News

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Yael L. Maxwell

August 12, 2015

Presentation

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

Presenter: Vera Bittner

August 11, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Daily News

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

August 06, 2015

Presentation

EES vs CABG for Patients With Diabetes and Multivessel Disease

Presenter: Sripal Bangalore

July 30, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

News Daily News

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

July 30, 2015

News Daily News

Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR

Todd Neale

July 27, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

Advertisement

Antisense Inhibition of Apolipoprotein C-III in Patients With Hypertriglyceridemia

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

BARI 2D: El Mayor Control de los Factores de Riesgo en Pacientes con Diabetes Tipo 2 Mejora Supervivencia

BARI 2D：改善 2 型糖尿病患者的危险因素控制情况可以提高其生存率

Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos

EES vs CABG for Patients With Diabetes and Multivessel Disease

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

RITA 3 Publicado: La Estrategia Invasiva Rutinaria en SCASEST Pierde su Ventaja a los 10 Años

Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content